½ÃÀ庸°í¼
»óÇ°ÄÚµå
1553431
°¡Á¤¿ë ¼ö¸é¹«È£Èí °Ë»ç ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Áö¿ªº°, ºÎ¹® ¿¹Ãø(2024-2030³â)Home Sleep Apnea Test Market Size, Share & Trends Analysis Report By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa), And Segment Forecasts, 2024 - 2030 |
Grand View Research, Inc.ÀÇ ÃֽŠ¸®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ °¡Á¤¿ë ¼ö¸é¹«È£Èí °Ë»ç ½ÃÀå ±Ô¸ð´Â 2024-2030³â CAGR 6.4%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 33¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.
½ÃÀå ¼ºÀåÀÇ ¹è°æ¿¡´Â °¡Á¤¿ë ¼ö¸é¹«È£Èí °Ë»ç(HSAT)ÀÇ ±â¼úÀû Áøº¸¸¦ ¸ñÇ¥·Î ÇÏ´Â À¯¸í ±â¾÷ÀÇ ÅõÀÚ Áõ°¡°¡ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 3¿ù Belun Technology Company Ltd.´Â Belun Ring Ç÷§ÆûÀÇ Æò°¡¸¦ À§ÇÑ ÀÓ»ó½ÃÇèÀ» ½ÃÀÛÇß½À´Ï´Ù. ¿þ¾î·¯ºí ±â¼úÀÎ Belun RingÀº ÀΰøÁö´É(AI)À» »ç¿ëÇÏ¿© ÀÇ·á Àü¹®°¡°¡ Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ(OSA)À» Áø´ÜÇÏ°í ¼ö¸é ´Ü°è¸¦ ºÐ·ùÇÏ´Â µ¥ µµ¿òÀ» ÁÙ ¼ö ÀÖ´Â ¿þ¾î·¯ºí ±â¼úÀÔ´Ï´Ù. Áý¿¡¼ÀÇ ¼ö¸é Æò°¡´Â °ËÁö ¼Õ°¡¶ô ±ÙÀ§ºÎ¿¡ Âø¿ëÇÏ´Â ÀÌ ¸µÇü Àåºñ¿¡ ÆÞ½º¿Á½Ã¹ÌÅÍ¿Í °¡¼Óµµ°è°¡ ³»ÀåµÇ¾î ÀÖ½À´Ï´Ù.
¶ÇÇÑ ¼ö¸é¹«È£ÈíÁõ À¯º´·ü Áõ°¡¿Í ¼ö¸é¹«È£ÈíÁõ Ä¡·á¸¦ À§ÇÑ ±â¼úÀûÀ¸·Î Áøº¸µÈ ¼Ö·ç¼ÇÀÇ °¡¿ë¼º¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇÑ ±¸»óÀÇ È®´ëµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù.2024³â 5¿ù National Council on Aging, Inc.°¡ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é ¾à 6¹é¸¸ ¸íÀÇ ¹Ì±¹ÀÎÀÌ ¼ö¸é¹«È£ÈíÁõÀ¸·Î °ø½Ä Áø´ÜÀ» ¹Þ¾ÒÀ¸¸ç, ¹Ì±¹³» 3,000¸¸ ¸í¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼ö¸é¹«È£ÈíÁõ À¯º´·üÀº ³ªÀÌ°¡ µé¼ö·Ï Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖÀ¸¸ç, ¿¬±¸¿¡ µû¸£¸é 65¼¼ ÀÌ»óÀÇ ¼ºÀÎÀº Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ ¹ßº´ À§ÇèÀÌ 56% ´õ ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.
COVID-19´Â ÃÖÁ¾»ç¿ëÀÚµéÀÌ ¿ø°ÝÀÇ·á ¼Ö·ç¼ÇÀ» äÅÃÇϵµ·Ï À¯µµÇÏ¿© ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, 2021³â 3¿ù Itamar MedicalÀÌ Sleep Medicine Publication°ú ÇÔ²² ½Ç½ÃÇÑ ¼³¹®Á¶»ç¿¡ µû¸£¸é ¼ö¸é Ŭ¸®´ÐÀÇ 29%°¡ °¡Á¤³» ¼Ö·ç¼Çº¸´Ù ½ÇÇè½Ç °Ë»ç¸¦ ¼±È£ÇÏ°í ÀÖÀ¸¸ç, ÀÌ ºñÀ²Àº ´õ ³·¾ÆÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ º¯È´Â ¹Ý¼ÛÀ̳ª ±â±â °Ë¿ªÀÌ ÇÊ¿ä ¾ø´Â ÀÏȸ¿ë °¡Á¤¿ë ¼ö¸é¹«È£Èí °Ë»ç(HSAT)ÀÇ µµÀÔ¿¡ ÈûÀÔÀº ¹Ù Å®´Ï´Ù. Áï°¢ÀûÀÎ °á°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â °¡Á¤¿ë ¼ö¸é¹«È£Èí °Ë»çÀÇ Çâ»óµÈ ±â´ÉÀº Ãʱ⠼±º°°Ë»çºÎÅÍ Áø´Ü, Ä¡·á±îÁö ȯÀÚÀÇ °æ°ú¸¦ ÀüÅëÀûÀÎ °Ë»ç½Ç °Ë»ç¿¡ ÀÇÁ¸ÇÏ´Â °æÇâÀ» ´õ¿í ¾àȽÃÄ×½À´Ï´Ù. COVID-19 ±â°£ Áß 67%ÀÇ Å¬¸®´ÐÀÌ ½ÇÇè½Ç ȯÀÚ °Ë»ç°¡ Áߵ¿¡¼ Å©°Ô °¨¼ÒÇß´Ù°í º¸°íÇÑ ¹Ý¸é, 66%´Â °¡Á¤¿ë ¼ö¸é¹«È£Èí °Ë»ç ÀÌ¿ëÀÌ ºñ½ÁÇÑ ¼öÁØÀ¸·Î Áõ°¡Çß´Ù°í ´äÇßÀ¸¸ç, 65%ÀÇ Å¬¸®´ÐÀº COVID-19 ÀÌÈÄ¿¡µµ ÀÌ·¯ÇÑ Ãß¼¼°¡ Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óÇÏ°í ¼ö¸é¹«È£ÈíÁõ ÁõÈıºÀÇ ÁÖ¿ä Áø´Ü ¼ö¸é¹«È£ÈíÁõ Áø´ÜÀÇ ÁÖ¿ä ¼ö´ÜÀ¸·Î HSAT¸¦ ¼±È£ÇÏ°í ÀÖ½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ÃÖÁ¾»ç¿ëÀÚÀÇ ÁøÈÇÏ´Â ¼ö¿ä¿¡ ´ëÀÀÇÏ°í ½ÃÀå¿¡¼ÀÇ ÀÔÁö¸¦ °ÈÇϱâ À§ÇØ ÀμöÇÕº´, ÆÄÆ®³Ê½Ê, Á¦ÈÞ, »ç¾÷ È®Àå, ½ÅÁ¦Ç° Ãâ½Ã µî ´Ù¾çÇÑ Àü·«À» äÅÃÇÏ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 3¿ù ¿µ±¹¿¡ º»»ç¸¦ µÐ ÀÇ·á ±â¼ú ±â¾÷ AcurableÀº ÃÖ±Ù FDAÀÇ ½ÂÀÎÀ» ¹Þ¾Æ ¹Ì±¹¿¡¼ Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ Áø´Ü¿ë AcuPebble Àåºñ¸¦ Ãâ½ÃÇÏ¿© ½ÃÀå ¹üÀ§¸¦ È®´ëÇß½À´Ï´Ù. ¿ø°Ý ¼ö¸é¹«È£Èí °Ë»ç ±â´ÉÀ» °ÈÇÏ¿© ½Å¼ÓÇÑ Áø´Ü, Ä¡·á ÃËÁø ¹× »óÅ °ü¸® °³¼±À» ÃËÁøÇÕ´Ï´Ù.
The global home sleep apnea test market size is expected to reach USD 3.38 billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to the increasing investment by prominent players, aimed at technological advancements in the home sleep apnea tests (HSAT). For instance, in March 2024, Belun Technology Company Ltd. launched a clinical trial aimed at the evaluation of the Belun Ring platform. The Belun Ring, a wearable technology, employs Artificial Intelligence (AI) to assist medical professionals in diagnosing Obstructive Sleep Apnea (OSA) and categorizing sleep phases. For home sleep assessments, individuals use this ring device, which incorporates a pulse oximeter and an accelerometer and is worn on the proximal index finger.
Moreover, the increasing prevalence of sleep apnea coupled with growing initiatives aimed at increasing awareness regarding the availability of technologically advanced solutions to treat sleep apnea is also contributing to the market growth. According to data published by the National Council on Aging, Inc. in May 2024 showcases that approximately 6 million Americans are formally diagnosed with sleep apnea; however, the condition is estimated to impact 30 million people within the U.S. The prevalence of sleep apnea tends to increase with age, the studies indicate that adults aged 65 and above exhibit a 56% higher risk of developing obstructive sleep apnea.
COVID-19 positively impacted the market as it forced the end users to adopt remote medical solutions. According to a survey conducted by Itamar Medical in partnership with Sleep Medicine Publication in March 2021 showcased that 29% of sleep clinics prioritize in-lab studies over at-home solutions-a proportion anticipated to decline further. This shift is supported by the adoption of disposable Home Sleep Apnea Tests (HSATs), which prevent the need for return shipping or equipment quarantine. Enhanced capabilities of home-based apnea tests, delivering instant results, further reduce the dependency on traditional in-lab studies for patient progression from initial screening through to diagnosis and treatment. During the pandemic, 67% of the clinics reported a moderate to significant reduction in in-lab patient studies, whereas 66% noted a comparable increase in the utilization of home sleep apnea tests. A substantial 65% of clinics foresee the continuation of this trend post-COVID, with a preference for HSATs as the primary diagnostic tool for sleep apnea.
Furthermore, key players in the market are adopting various strategies such as mergers & acquisitions, partnerships, collaborations, expansions, and new product launches to cater to the evolving demand of end users and strengthen their market positions. For instance, in March 2023, UK-based medical technology firm Acurable expanded its market reach by launching the AcuPebble device for the diagnosis of obstructive sleep apnea in the U.S. following recent FDA approval. Initially introduced in Europe in 2021, this device enhances the capability for remote, home-based sleep apnea testing, facilitating prompt diagnosis, accelerated treatment, and improved management of the condition.